Thu, June 7, 2012
Wed, June 6, 2012
Tue, June 5, 2012
Mon, June 4, 2012
Sat, June 2, 2012
Fri, June 1, 2012
Thu, May 31, 2012
Wed, May 30, 2012
Tue, May 29, 2012
Mon, May 28, 2012
Sun, May 27, 2012
Sat, May 26, 2012
Fri, May 25, 2012
Thu, May 24, 2012

Keryx Biopharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference


//health-fitness.news-articles.net/content/2012/ .. jefferies-2012-global-healthcare-conference.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


Keryx Biopharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference -- NEW YORK, May 31, 2012 /PRNewswire/ --

Keryx Biopharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference

[ ]

Presentation Scheduled for Monday, June 4th at 1:00pm ET

NEW YORK, May 31, 2012 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: [ KERX ]) today announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at Jefferies 2012 Global Healthcare Conference, which will be held in New York City.  Mr. Bentsur's presentation is scheduled to take place on Monday, June 4, 2012 at 1:00 p.m. ET

A live audio webcast of Mr. Bentsur's presentation will be accessible from the Investor Information page of the Company's Website at [ http://investors.keryx.com ]. An archived version of the webcast will be available following the conclusion of the live presentation.

About Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease. Keryx is developing Zerenex (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. The Phase 3 clinical program of Zerenex for the treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease is being conducted pursuant to a Special Protocol Assessment (SPA) agreement with the FDA. Keryx is headquartered in New York City.

KERYX CONTACT:
Lauren Fischer
Director – Investor Relations
Keryx Biopharmaceuticals, Inc.
Tel: 212.531.5965
E-mail: [ lfischer@keryx.com ]

SOURCE Keryx Biopharmaceuticals, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.keryx.com ]


Publication Contributing Sources

Publication Sponsors
[ Last Sunday ] - Oceanside Rental Gear